Ozurdex (Dexamethasone)

Dexamethasone, the active ingredient in Ozurdex, is a corticosteroid presented as a sustained‑release intravitreal implant for ocular use. It treats macular edema associated with retinal vein occlusion, non‑infectious uveitis and diabetic macular edema in adult patients. GNH USA supplies Ozurdex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and ophthalmology clinics worldwide.

GNH USA supplies Ozurdex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and ophthalmology clinics worldwide.

Ozurdex is a corticosteroid implant that delivers medication directly to the eye, addressing several retinal conditions. - Macular edema secondary to retinal vein occlusion: reduces swelling and improves visual acuity. - Non‑infectious intermediate, posterior or pan‑uveitis: provides sustained anti‑inflammatory effect. - Diabetic macular edema: decreases fluid accumulation and stabilises vision.

Ozurdex may cause ocular and systemic adverse reactions.

Common Side Effects: - Elevated intra‑ocular pressure: transient rise that often responds to topical therapy. - Cataract formation: accelerated progression of lens opacity. - Conjunctival hemorrhage: minor bleeding at the injection site. - Vitreous floaters: perception of moving specks in the visual field. - Mild ocular discomfort: temporary irritation after implantation.

Serious or Rare Side Effects: - Endophthalmitis: severe intra‑ocular infection requiring urgent treatment. - Persistent elevated intra‑ocular pressure: may need surgical intervention. - Retinal detachment: separation of the retina from underlying tissue. - Implant migration: movement of the device to an unintended ocular compartment.

Before using Ozurdex, clinicians should evaluate patient history and ocular status. - Glaucoma: assess baseline intra‑ocular pressure and monitor regularly. - Ocular infection: avoid implantation in eyes with active infection. - Recent ocular surgery: defer implantation until adequate healing. - Steroid response: watch for rapid pressure spikes after injection. - Systemic corticosteroid use: consider cumulative steroid exposure. - Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Ozurdex can interact with other ocular and systemic therapies.

Major Interactions (Avoid): - Systemic immunosuppressants: may increase risk of infection. - Potent topical corticosteroids: additive intra‑ocular pressure rise.

Moderate Interactions (Monitor Closely): - Antiglaucoma medications: may require dose adjustment. - Anticoagulants antico :   - Anti‑VEGF agents: timing of administration should be coordinated. - Intravitreal antibiotics :   - CYP